Discover how health economics can support successful Medical Device launch, proposition development, and market access
Join us live at 1:30pm (GMT) on Wednesday 19th March for an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams will explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders, communicating value and demonstrating evidence, and offer tips on leveraging health economics for a successful launch.
In this webinar, Juliet Wallace (Senior Partnerships Coordinator) will delve deep with our expert panel into the pivotal role of health economic evaluation in supporting market access for medical devices. Juliet will put your questions to Hannah Palin (Director, Local Market Access), Calum Jones (Associate Director, Health Economics), and Evelyne Priestman (Consultant, Health Economics).
Hannah Palin
Hannah Palin specialises in the launch and commercialisation of new healthcare interventions. She is an expert in developing materials that communicate the clinical and economic value that products deliver within the care pathway. Hannah will draw on her experiences creating local launch strategies for a wide range of Medtech products.
Calum Jones
Calum Jones has deep expertise with early economics models to support strategic decision making, reimbursement and HTA. These types of models are a staple of Pharma market access, but are often overlooked by Medical Device teams. Calum will help us understand the value early modelling and evaluation can add for Medtech.
Evelyne Priestman
Evelyne Priestman’s expertise lies in leveraging health economic modelling for the commercialisation and launch of medical devices. Evelyne will discuss the common obstacles that launch teams encounter when introducing new devices to local markets, and how health economics can generate the evidence needed to navigate these challenges successfully.
Together they will discuss:
- Product claims and value proposition: How to navigate the complexities of defining and communicating your device’s value to various stakeholders; and how to ensure key claims in your value proposition are supported by clinical and economic evidence
- Care pathway mapping: How care pathway mapping, combined with effective modelling can identify the optimal positioning of a medical device within healthcare systems. Where and how will your device slot into the existing care pathway? How can you demonstrate that your device will add value to the care pathway?
- Decision-analytical modelling: Explore with our panel how early models can shape your strategy, providing a foundation for informed decision-making. Early modelling can help you identify which product claims generate the greatest impact. Modelling can also help you determine pricing strategy and quantify the potential budgetary savings and health outcomes for your future customers
- How early modelling can help secure a pilot: How early value models can be used to convince healthcare stakeholders in primary and secondary care invest in a pilot. How then to utilise data collected in pilots to further strengthen your evidence base and secure broader rollout
- Health Economic evaluations: Types of health economic evaluations and how they are best used to support Medtech commercialisation and launch
- Value communication: Get advice on crafting compelling narratives around your data to influence and persuade. How to package health economic data in an intuitive and accessible way, that is easy to communicate to busy healthcare leaders
Register now to join us live at 1:30pm (GMT) on Wednesday 19th March or to access the recording later!
Please do register, even if you can’t attend on the day, as all registrants will receive the recording after the event.
Who should attend?
This webinar is perfect for those responsible for bringing new medical devices to market, who may be wondering where and how health economics can support their strategy, proposition, and launch. If you’re looking for inspiration and practical advice from those who have worked on a wide range of medical device launches, this is for you.
Don’t miss this opportunity to gain first-hand knowledge from our specialists who have navigated these challenges successfully.
The webinar is free and open to all market access, evidence strategy, health economics and outcomes research (HEOR), and value communication teams in Medical Device, Diagnostic, and Pharmaceutical companies. Some colleagues from other organisations may attend at the discretion of Mtech Access – Powered by Petauri.
